Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00404079
Status:
COMPLETED
Last Update Posted:
2011-04-29
First Post:
2006-11-23
Brief Title:
The Glucosamine-study The Effect of Glucosamine in Treatment of Chronic Low Back Pain
Sponsor:
Ullevaal University Hospital
Organization:
Oslo University Hospital
Study Overview
Official Title:
Phase 4 Study of Glucosamine Sulphate in the Treatment for Chronic Low Back Pain Patients With Degenerative Lumbar MRI Findings
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Low back pain LBP is the most frequent cause of sick leave and disability pension and degenerative and osteoarthritic OA changes is a significant cause of pain and disability Some indications exist for symptomatic and possible cartilage-structurmodifying effect on knee- and hip-osteoarthritis with glucosamine sulphate GS The OA process in the lumbar spine is most likely to OA processes in knees and hips hence GS could have comparable symptomatic and structural effect on lumbar OA
Study hypothesis No difference in treatment effect exists between oral intake of GS- or placebo-capsules for patients with chronic low back pain measured with Roland Morris Disability Questionnaire
Study hypothesis No difference in treatment effect exists between oral intake of GS- or placebo-capsules for patients with chronic low back pain measured with Roland Morris Disability Questionnaire
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None